JP Morgan European Healthcare CEO Call Series (4pm CET) - Global
Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Newsroom arrow down
      < Back
    • Newsroom
    • Press Releases
    • Media Updates
    • Media Library
    • Contacts
    • Subscribe
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Annual Reports & Accounts
    • Investor Events
    • Financial Calendar
    • Corporate News
    • Regulated Information
    • Shareholder Information
    • Contacts
    • Subscribe
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
    • Job Search
  • Contacts arrow down
      < Back
    • Contacts
    • Contacts
    • Our Locations
    • Report Side Effects
    • Subscribe
  • Press shift tab to select search category
    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Global
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Expertise
      < Back
    • Expertise
    • Oncology
    • Rare Disease
    • Neuroscience
    • Medicines
  • Science
      < Back
    • Science
    • Science
        < Back
      • Science
      • Oncology
      • Rare Disease
      • Neuroscience
    • Profiles
    • Partnering
        < Back
      • Partnering
      • Therapeutic focus
      • Meet the team
    • Clinical Trials
        < Back
      • Clinical Trials
      • Lay Summaries
      • Find Clinical Trials
    • Pipeline
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Our Standards
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Collaborate with us
  • Stories
  1. Home
  2. Events
  3. Other Investor Event events

JP Morgan European Healthcare CEO Call Series (4pm CET)

Post navigation

Previous
Next

JP Morgan European Healthcare CEO Call Series (4pm CET)

JP Morgan European Healthcare CEO Call Series (4pm CET)

Add to Calendar - 09 September 2024 - 0 mins read

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook
Related Documents
  • Ipsen - September 2024   Download  (2 MB)

Related Events

ODDO BHF Forum 2026
09 January 2026 1 mins read

ODDO BHF Forum 2026
EU Healthcare Bus Tour
01 September 2025 0 mins read

EU Healthcare Bus Tour
Back to School Healthcare Series (4:00 – 4:45 PM CET)
03 September 2025 0 mins read

Back to School Healthcare Series (4:00 – 4:45 PM CET)
Forum by Market Solutions
12 September 2025 0 mins read

Forum by Market Solutions
BioVoyage – EU Biopharma Bus Tour 2025
03 September 2025 0 mins read

BioVoyage – EU Biopharma Bus Tour 2025
CIC sales briefing – Paris
09 October 2024 0 mins read

CIC sales briefing – Paris
Deutsche C-suite call series: fireside chat
20 November 2024 0 mins read

Deutsche C-suite call series: fireside chat
Stifel European Healthcare Summit, Lyon
27 June 2024 0 mins read

Stifel European Healthcare Summit, Lyon
Barclays 2023 Conversations with the C-Suite
12 December 2023 0 mins read

Barclays 2023 Conversations with the C-Suite
ODDO BHF Forum, Lyon
12 January 2024 0 mins read

ODDO BHF Forum, Lyon

IPN price

€124.30

 €-0.10 (-0.08%)

  • Media Library
  • Annual Report
  • Contacts
  • Our Locations
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website. To continue, please click on Continue?

Continue